Trials / Terminated
TerminatedNCT02728167
Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy
Randomized, Open-label, Phase II Study to Evaluate the Efficacy of High-Intensity Focused Ultrasound Assisted Hepatic Resection (HIFU-AR) on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Centre Leon Berard · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether HIFU-assisted liver resection (HIFU-AR) results in reduced blood loss compared to standard liver resection in patients with LM.This is a prospective, monocentric, randomized (1:1 ratio), comparative, open-label Phase II study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pre-coagulation of the liver parenchyma with HIFU | 6 to 10 (or more if necessary) side-to-side 40-seconde HIFU treatments |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2018-07-01
- Completion
- 2018-08-01
- First posted
- 2016-04-05
- Last updated
- 2018-08-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02728167. Inclusion in this directory is not an endorsement.